| |
| |
|
| Insider
Information: |
Teehan Brendan |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
38,796 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$648,281 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
38,796 |
|
|
| Total
Value |
$648,281 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-04-08 |
38,796 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, HEAD OF COMMERCIAL |
• – – |
2024-04-08 |
4 |
AS |
$17.87 |
$45,890 |
D/D |
(2,568) |
38,796 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, HEAD OF COMMERCIAL |
• – – |
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,024 |
41,364 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, HEAD OF COMMERCIAL |
• – – |
2024-03-27 |
4 |
AS |
$17.90 |
$92,006 |
D/D |
(5,140) |
36,340 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, HEAD OF COMMERCIAL |
• – – |
2024-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,048 |
41,480 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, HEAD OF COMMERCIAL |
• – – |
2024-02-26 |
4 |
AS |
$24.67 |
$15,394 |
D/D |
(624) |
31,432 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, HEAD OF COMMERCIAL |
• – – |
2024-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,107 |
32,056 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2024-01-08 |
4 |
S |
$29.96 |
$21,901 |
D/D |
(731) |
30,949 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,287 |
31,680 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-11-20 |
4 |
S |
$22.64 |
$112,294 |
D/D |
(4,960) |
30,393 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,912 |
35,353 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-05-17 |
4 |
S |
$22.50 |
$334,553 |
D/D |
(14,869) |
24,356 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,738 |
39,225 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-05-01 |
4 |
S |
$21.18 |
$11,607 |
D/D |
(548) |
9,487 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,567 |
10,035 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-04-06 |
4 |
S |
$18.16 |
$31,798 |
D/D |
(1,751) |
8,468 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,024 |
10,219 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-02-24 |
4 |
S |
$18.78 |
$8,658 |
D/D |
(461) |
5,195 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,107 |
5,656 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-01-09 |
4 |
S |
$17.13 |
$9,113 |
D/D |
(532) |
4,549 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2023-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,286 |
5,081 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2022-05-02 |
4 |
S |
$18.18 |
$10,036 |
D/D |
(552) |
3,437 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,567 |
3,989 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2022-02-23 |
4 |
S |
$23.80 |
$11,234 |
D/D |
(472) |
2,422 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2022-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,106 |
2,894 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, COO, Head of Commercial |
• – – |
2022-01-06 |
4 |
S |
$23.05 |
$12,401 |
D/D |
(538) |
1,788 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
